Last updated: 16 June 2019 at 4:12pm EST

Steven H Holtzman Net Worth




The estimated Net Worth of Steven H Holtzman is at least $8.28 Million dollars as of 23 February 2016. Steven Holtzman owns over 579 units of Infinity Pharmaceuticals stock worth over $172 and over the last 18 years Steven sold INFI stock worth over $8,278,747.

Steven Holtzman INFI stock SEC Form 4 insiders trading

Steven has made over 23 trades of the Infinity Pharmaceuticals stock since 2012, according to the Form 4 filled with the SEC. Most recently Steven exercised 579 units of INFI stock worth $12 on 23 February 2016.

The largest trade Steven's ever made was selling 200,261 units of Infinity Pharmaceuticals stock on 29 May 2012 worth over $2,603,393. On average, Steven trades about 7,664 units every 36 days since 2006. As of 23 February 2016 Steven still owns at least 8,599 units of Infinity Pharmaceuticals stock.

You can see the complete history of Steven Holtzman stock trades at the bottom of the page.



What's Steven Holtzman's mailing address?

Steven's mailing address filed with the SEC is BIOGEN IDEC INC., 133 BOSTON POST ROAD, WESTON, MA, 02493.

Insiders trading at Infinity Pharmaceuticals

Over the last 18 years, insiders at Infinity Pharmaceuticals have traded over $485,846,497 worth of Infinity Pharmaceuticals stock and bought 22,639,120 units worth $175,155,554 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Partners L P/Ilbiotechnolog..., and Medical Co L.P. Rosebay. On average, Infinity Pharmaceuticals executives and independent directors trade stock every 70 days with the average trade being worth of $14,976. The most recent stock trade was executed by Adelene Q Perkins on 8 September 2023, trading 768,133 units of INFI stock currently worth $15,363.



What does Infinity Pharmaceuticals do?

the mission of infinity pharmaceuticals, inc. is to discover, develop, and deliver to patients best-in-class medicines for the treatment of difficult-to-treat diseases, with a strong focus in oncology and inflammation. small molecule discovery and development capabilities infinity’s programs arise from the integration of a broad range of research and development capabilities, including strengths in cancer biology, medicinal chemistry, clinical and translational medicine, and drug product process development and formulation. strategic alliances building on its strengths in innovative small molecule drug discovery and development, infinity has established significant alliances with leading pharmaceutical and biotechnology companies to help realize the full potential of its product pipeline. business and scientific expertise the company has assembled a team of passionate, committed, and innovative individuals who bring together their collective expertise in all areas of business



What does Infinity Pharmaceuticals's logo look like?

Infinity Pharmaceuticals Inc. logo

Complete history of Steven Holtzman stock trades at Biogen Inc and Infinity Pharmaceuticals

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
23 Feb 2016 Steven H Holtzman
EVP Corp Devel and Strategy
Option 579 $258.99 $149,955
23 Feb 2016
8,599
12 Feb 2016 Steven H Holtzman
EVP Corp Devel and Strategy
Option 3,194 $247.22 $789,621
12 Feb 2016
8,839
8 Feb 2016 Steven H Holtzman
EVP Corp Devel and Strategy
Option 2,709 $250.77 $679,336
8 Feb 2016
7,030
17 Feb 2015 Steven H Holtzman
EVP Corp Devel and Strategy
Sale 2,128 $389.11 $828,026
17 Feb 2015
4,321
12 Feb 2015 Steven H Holtzman
EVP Corp Devel and Strategy
Option 3,634 $392.11 $1,424,928
12 Feb 2015
7,152
8 Feb 2015 Steven H Holtzman
EVP Corp Devel and Strategy
Option 2,705 $402.00 $1,087,410
8 Feb 2015
5,802
1 Feb 2015 Steven H Holtzman
EVP Corp Devel and Strategy
Option 5,157 $389.16 $2,006,898
1 Feb 2015
5,157
2 Dec 2014 Steven H Holtzman
EVP Corp Devel and Strategy
Sale 1,749 $335.65 $587,052
2 Dec 2014
0
11 Nov 2014 Steven H Holtzman
EVP Corp Devel and Strategy
Sale 1,750 $330.00 $577,500
11 Nov 2014
1,749
1 Oct 2014 Steven H Holtzman
EVP Corp Devel and Strategy
Sale 1,750 $330.97 $579,198
1 Oct 2014
3,499
19 May 2014 Steven H Holtzman
EVP Corp Devel and Strategy
Sale 1,221 $289.15 $353,052
19 May 2014
5,749
17 Apr 2014 Steven H Holtzman
EVP Corp Devel and Strategy
Sale 1,221 $291.00 $355,311
17 Apr 2014
6,970
17 Mar 2014 Steven H Holtzman
EVP Corp Devel and Strategy
Sale 1,221 $334.83 $408,827
17 Mar 2014
8,191
18 Feb 2014 Steven H Holtzman
EVP Corp Devel and Strategy
Sale 1,222 $327.90 $400,694
18 Feb 2014
9,412
12 Feb 2014 Steven H Holtzman
EVP Corp Devel and Strategy
Option 2,142 $323.04 $691,952
12 Feb 2014
11,644
8 Feb 2014 Steven H Holtzman
EVP Corp Devel and Strategy
Option 2,705 $315.54 $853,536
8 Feb 2014
10,778
1 Feb 2014 Steven H Holtzman
EVP Corp Devel and Strategy
Option 5,159 $312.64 $1,612,910
1 Feb 2014
10,044
17 Sep 2013 Steven H Holtzman
EVP Corp Devel and Strategy
Sale 3,501 $238.98 $836,669
17 Sep 2013
4,885
8 Feb 2013 Steven H Holtzman
EVP Corp Devel and Strategy
Option 2,344 $164.44 $385,447
8 Feb 2013
9,326
1 Feb 2013 Steven H Holtzman
EVP Corp Devel and Strategy
Option 5,159 $157.30 $811,511
1 Feb 2013
8,660
1 Feb 2012 Steven H Holtzman
EVP Corp Devel and Strategy
Option 5,159 $121.26 $625,580
1 Feb 2012
5,159
31 May 2012 Steven H Holtzman
CEO and Assistant Secretary
Sale 57,573 $13.01 $749,025
31 May 2012
0
29 May 2012 Steven H Holtzman
CEO and Assistant Secretary
Sale 200,261 $13.00 $2,603,393
29 May 2012
57,573


Infinity Pharmaceuticals executives and stock owners

Infinity Pharmaceuticals executives and other stock owners filed with the SEC include: